Literature DB >> 17394690

Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission.

R Vázquez-Gallardo1, L Anibarro, A Fernández-Villar, D Díaz-Cabanela, E Cruz-Ferro, M L Pérez del Molino, V Túñez, S Samper, M J Iglesias.   

Abstract

OBJECTIVE: To describe the characteristics of patients with multidrug-resistant tuberculosis (MDR-TB), a descriptive prospective study was carried out applying a combination of exhaustive conventional epidemiology with molecular genotyping.
SETTING: All patients diagnosed with MDR-TB in Galicia, Spain, between 1998 and 2004 were included in the study.
DESIGN: Of 9895 diagnosed cases of TB, 58 were MDR-TB (0.59%). The site of disease was pulmonary in 56 cases and 46 were smear-positive. Only two cases were co-infected with the human immunodeficiency virus (HIV) and seven were immigrants. Twenty-five (43%) had received previous TB treatment. These cases presented more risk factors for treatment default and a lower frequency of contact with cases of MDR-TB.
RESULTS: Genotyping analysis was performed in 57 patients, showing evidence of four clusters (30 patients, 52.6%), each with identical genetic patterns. The patients included in the clusters were younger, and most had primary forms or had had contact with another case of MDR-TB, especially in hospital. Neither the Beijing/W nor the B strain was identified.
CONCLUSION: There is a low prevalence of MDR-TB in Galicia. Unlike previous studies, there was a high rate of transmissibility, including nosocomial transmission. Transmission is not associated with HIV or previously reported strains with a high capacity for transmission.

Entities:  

Mesh:

Year:  2007        PMID: 17394690

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

2.  Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment.

Authors:  Timothy F Brewer; Howard W Choi; Carlos Seas; Fiorella Krapp; Carlos Zamudio; Lena Shah; Antonio Ciampi; S Jody Heymann; Eduardo Gotuzzo
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

3.  Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007.

Authors:  John Z Metcalfe; Elizabeth Y Kim; S-Y Grace Lin; Adithya Cattamanchi; Peter Oh; Jennifer Flood; Philip C Hopewell; Midori Kato-Maeda
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

4.  Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.

Authors:  Wei-Bin Li; Yan-Qiu Zhang; Jin Xing; Zhen-Ya Ma; Ya-Hong Qu; Xin-Xu Li
Journal:  Infect Dis Poverty       Date:  2015-03-24       Impact factor: 4.520

5.  Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.

Authors:  James Johnston; Andrew Admon; Amir Ibrahim; Kevin Elwood; Patrick Tang; Victoria Cook; Mark Fitzgerald
Journal:  BMC Infect Dis       Date:  2012-10-22       Impact factor: 3.090

6.  Dominant incidence of multidrug and extensively drug-resistant specific Mycobacterium tuberculosis clones in Osaka Prefecture, Japan.

Authors:  Aki Tamaru; Chie Nakajima; Takayuki Wada; Yajun Wang; Manabu Inoue; Ryuji Kawahara; Ryoji Maekura; Yuriko Ozeki; Hisashi Ogura; Kazuo Kobayashi; Yasuhiko Suzuki; Sohkichi Matsumoto
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.